The p53 tumor suppressor gene in breast cancer (original) (raw)
References
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Science 253:252–254, 1991 Google Scholar
Osborne RJ, Merlo GR, Mitsudomi T, Venesio T, Liscia DS, Cappa APM, Chiba I, Takahashi T, Nau MM, Callahan R, Minna JD: Mutations in the p53 gene in primary human breast cancers. Cancer Res 51:6194–6198, 1991 Google Scholar
Noble JR, Willetts KE, Mercer WE, Reddel RR: Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53. Exper Cell Res 203:297–304, 1992 Google Scholar
Cajot J-F, Anderson MJ, Lehman TA, Shapiro H, Briggs AA, Stanbridge EJ: Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein. Cancer Res 52:6956–6960, 1992 Google Scholar
Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 57:1083–1093, 1989 Google Scholar
Funk WD, Pak DT, Karas RH, Wright WE, Shay JW: A transcriptionally active DNA-binding site for human p53 protein complexes. Molec Cell Biol 12:2866–2871, 1992 Google Scholar
Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B: Identification of p53 as a sequence-specific DNA-binding protein. Science 252:1708–1711, 1991 Google Scholar
Mack DH, Vartikar J, Pipas JM, Laimins LA: Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature 363:281–283, 1993 Google Scholar
Fields S, Jang SK: Presence of a potent transcription activating sequence in the p53 protein. Science 249:1046–1049, 1990 Google Scholar
Seto E, Usheva A, Zambetti GP, Momand J, Horikoshi N, Weinmann R, Levine AJ, Shenk T: Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci USA 89:12028–12032, 1992 Google Scholar
Ramqvist T, Magnusson KP, Wang Y, Szekely L, Klein G, Wiman KG: Wild-type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53. Oncogene 8:1495–1500, 1993 Google Scholar
Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345–347, 1991 Google Scholar
Kastan MB, Onyekwere O, Sidransky D, Vogelstein B, Craig RW: Participation of p53 protein in the cellular response to DNA damage. Cancer Res 51:6304–6311, 1991 Google Scholar
Livingstone LR, White A, Sprouse J, Livanos E, Jacks T, Tlsty TD: Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell 70:923–935, 1992 Google Scholar
Feinstein E, Gale RP, Reed J, Canaani E: Expression of the normal p53 gene induces differentiation of K562 cells. Oncogene 7:1853–1857, 1992 Google Scholar
Yin Y, Tainsky MA, Bischoff FZ, Strong LC, Wahl GM: Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 70:937–948, 1992 Google Scholar
Lin D, Shields MT, Ullrich SJ, Appella E, Mercer WE: Growth arrest induced by wild-type p53 protein blocks cells prior to or near the restriction point in late G1 phase. Proc Natl Acad Sci USA 89:9210–9214, 1992 Google Scholar
Michalovitz D, Halevy O, Oren M: Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62:671–680, 1990 Google Scholar
Rovinski B, Benchimol S: Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene 2:445–452, 1988 Google Scholar
Jenkins JR, Rudge K, Currie GA: Cellular immortalization by a cDNA clone encoding the transformationassociated phosphoprotein p53. Nature 312:651–654, 1984 Google Scholar
Tsuda H, Iwaya K, Fukutomi T, Hirohashi S: p53 mutations and c-erbB-2 amplification in intraductal and invasive breast carcinomas of high histologic grade. Jpn J Cancer Res 84:394–401, 1993 Google Scholar
Davidoff AM, Kerns B-JM, Pence JC, Marks JR, Iglehart JD: p53 alterations in all stages of breast cancer. J Surg Oncol 48:260–267, 1991 Google Scholar
Thor AD, Moore DH II, Edgerton SM, Kawasaki ES, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen L-C, Mayall BH, Smith HS: Accumulation of p53 tumor suppressor gene protein: An independent marker of prognosis in breast cancer. J Natl Cancer Inst 84:845–855, 1992 Google Scholar
Runnebaum IB, Nagarajan M, Bowman M, Soto D, Sukumar S: Mutations in p53 as potential molecular markers for human breast cancer. Proc Natl Acad Sci USA 88:10657–10661, 1991 Google Scholar
Bártek J, Bártková J, Voitesek B, Stasková Z, Rejthar A, Kovarik J, Lane DP: Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours_in situ_ and_in vitro_. Int J Cancer 46:839–844, 1990 Google Scholar
Mazars R, Spinardi L, BenChikh M, Simony-Lafontaine J, Jeanteur P, Theillet C: p53 mutations occur in aggressive breast cancer. Cancer Res 52:3918–3923, 1992 Google Scholar
Davidoff AM, Humphrey PA, Iglehart JD, Marks JR: Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5006–5010, 1991 Google Scholar
Davidoff AM, Kerns B-JM, Iglehart JD, Marks JR: Maintenance of p53 alterations throughout breast cancer progression. Cancer Res 51:2605–2610, 1991 Google Scholar
Allred DC, Clark GM, Elledge R, Fuqua SAW, Brown RW, Chamness GC, Osborne CK, McGuire WL: Association of p53 protein expression with tumor cell proliferation rate and clinical outcome in node-negative breast cancer. J Natl Cancer Inst 85:200–206, 1993 Google Scholar
Elledge RM, Fuqua SAW, Clark GM, Pujol P, Allred DC, McGuire WL: Prognostic significance of p53 gene alterations in node-negative breast cancer. Breast Cancer Res Treat 26:225–235, 1993 Google Scholar
Marchetti A, Buttitta F, Pellegrini S, Campani D, Diella F, Cecchetti D, Callahan R, Bistocchi M: p53 mutations and histological type of invasive breast carcinoma. Cancer Res 53:4665–4669, 1993 Google Scholar
Coles C, Condie A, Chetty U, Steel CM, Evans J, Prosser J: p53 mutations in breast cancer. Cancer Res 52:5291–5298, 1992 Google Scholar
Wu JK, Ye Z, Darras BT: Sensitivity of single-strand conformation polymorphism (SSCP) analysis in detecting p53 point mutations in tumors with mixed cell populations. Am J Hum Genet 52:1273–1275, 1993 Google Scholar
Barnes DM, Hanby AM, Gillett CE, Mohammed S, Hodgson S, Bobrow LG, Leigh IM, Purkis T, MacGeoch C, Spurr NK, Bartek J, Vojtesek B, Picksley SM, Lane DP: Abnormal expression of wild type p53 protein in normal cells of a cancer family patient. Lancet 340:259–263, 1992 Google Scholar
Shaulsky G, Ben-Ze'ev A, Rotter V: Subcellular distribution of the p53 protein during the cell cycle of Balb/c 3T3 cells. Oncogene 5:1701–1711, 1990 Google Scholar
Momand J, Zambetti GP, Olson DC, George D, Levine AJ: The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237–1245, 1992 Google Scholar
Iwaya K, Tsuda H, Hiraide H, Tamaki K, Tamakuma S, Fukutomi T, Mukai K, Hirohashi S: Nuclear p53 immunoreaction associated with poor prognosis of breast cancer. Jpn J Cancer Res 82:835–840, 1991 Google Scholar
Hanzal E, Gitsch G, Kohlberger P, Dadak CH, Miechowiecka N, Breitenecker G: Immunohistochemical detection of mutant p53-suppressor gene product in patients with breast cancer: Influence on metastasis-free survival. Anticancer Res 12:2325–2330, 1992 Google Scholar
Barnes DM, Dublin EA, Fisher CJ, Levison DA, Millis RR: Immunohistochemical detection of p53 protein in mammary carcinoma: An important new independent indicator of prognosis? Hum Pathol 24:469–476, 1993 Google Scholar
Ostrowski JL, Sawan A, Henry L, Wright C, Henry JA, Hennessy C, Lennard JW, Angus B, Horne HW: p53 expression in human breast cancer related to survival and prognostic factors: An immunohistochemical study. J Pathol 164:75–81, 1991 Google Scholar
Isola J, Visakorpi T, Holli K, Kallioniemi O-P: Association of overexpression of tumor suppressor protein p53 with rapid cell proliferation and poor prognosis in node-negative breast cancer patients. J Natl Cancer Inst 84:1109–1114, 1992 Google Scholar
Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronesi U: p53 as an independent prognostic marker in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965–970, 1993 Google Scholar
Allred DC, Clark GM, Fuqua SAW, Elledge RM, Hilsenbeck SG, Ravdin PM, Yee D, Chamness GC, Osborne CK: Overexpression of p53 in node-positive breast cancer. Breast Cancer Res Treat 27:131, 1993 Google Scholar
Noguchi M, Kitagawa H, Kinoshita K, Miyazaki I, Saito Y, Mizukami Y: Prognostic significance of p53 and c-erbB-2 experience in operable breast cancer. Int J Oncol (Greece) 2:587–591, 1993 Google Scholar
Sidransky D, Mikkelsen T, Schwechheimer K, Rosenblum ML, Cavanee W, Vogelstein B: Clonal expansion of p53 mutant cells is associated with brain tumour progression. Nature 355:846–847, 1992 Google Scholar
Thorlacius S, Börresen A-L, Eyfjörd E: Somatic p53 mutations in human breast carcinomas in an Icelandic population: A prognostic factor. Cancer Res 53:1637–1641, 1993 Google Scholar
Wilson AC, Singh M, Thompson HJ: Morphological responses of MOD cells to tamoxifen suggests induction of apoptosis. Proc Am Asso Cancer Res 33:151, 1993 Google Scholar
Kyprianou N, English HF, Davidson NE, Isaacs JT: Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 51:162–166, 1991 Google Scholar
Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB: Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417–428, 1987 Google Scholar
Gerwin BI, Spillare E, Forrester K, Lehman TA, Kispert S, Welsh JA, Pfeifer AMS, Lechner JF, Baker LJ, Vogelstein B, Harris CC: Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor β1. Proc Natl Acad Sci USA 89:2759–2763, 1992 Google Scholar
Finlay CA, Hinds PW, Tan T-H, Eliyahu D, Oren M, Levine AJ: Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life. Mol Cell Biol 8:531–539, 1988 Google Scholar
Yehiely F, Oren M: The gene for the rat heat-shock cognate,hsc70, can suppress oncogene-mediated transformation. Cell Growth Diff 3:803–809, 1992 Google Scholar
Lehman TA, Bennett WP, Metcalf RA, et al: p53 mutations,ras mutations, and p53-heat shock protein 70 complexes in human lung carcinoma cell lines. Cancer Res 51:4090–4096, 1991 Google Scholar